Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly

被引:65
作者
Ducki, S
Mackenzie, G
Lawrence, NJ
Snyder, JP
机构
[1] Univ Salford, Ctr Mol Drug Design, Salford M5 4WT, Lancs, England
[2] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[3] Cardiff Univ, Dept Chem, Cardiff CF10 3TB, S Glam, Wales
关键词
D O I
10.1021/jm049444m
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
A molecular modeling study was carried out to develop a predictive model for combretastatin-like analogues populating the colchicine-binding site of beta-tubulin. A series of compounds built. around a framework including two aromatic groups linked by various moieties such as alkenes (stilbenes), enones (chalcones), or ethers was selected for the study. The 5D-QSAR model was developed stepwise. First a model was generated for the chalcone series (19 compounds. 71 conformations), then for the stilbene series (18 compounds. 59 conformations), and finally for the combined dataset (47 ligands, 160 conformers). Although the models for the chalcone and stilbene series appeared slightly different when represented by QSAR colored surfaces, the combined model seems to reconcile the differences without compromise and represents a highly predictive model for compounds that bind to the colchicine-binding, site of tubulin.
引用
收藏
页码:457 / 465
页数:9
相关论文
共 42 条
[1]
Role of the colchicine ring a and its methoxy groups in the binding to tubulin and microtubule inhibition [J].
Andreu, JM ;
Perez-Ramirez, B ;
Gorbunoff, MJ ;
Ayala, D ;
Timasheff, SN .
BIOCHEMISTRY, 1998, 37 (23) :8356-8368
[2]
Mapping the binding site of colchicinoids on β-tubulin -: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354 [J].
Bai, RL ;
Covell, DG ;
Pei, XF ;
Ewell, JB ;
Nguyen, NY ;
Brossi, A ;
Hamel, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40443-40452
[3]
ATOMIC CHARGES DERIVED FROM SEMIEMPIRICAL METHODS [J].
BESLER, BH ;
MERZ, KM ;
KOLLMAN, PA .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :431-439
[4]
Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on β-tubulin [J].
Brown, ML ;
Rieger, JM ;
Macdonald, TL .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (06) :1433-1441
[5]
The development of combretastatin A4 phosphate as a vascular targeting agent [J].
Chaplin, DJ ;
Hill, SA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1491-1496
[6]
Potent antimitotic and cell growth inhibitory properties of substituted chalcones [J].
Ducki, S ;
Forrest, R ;
Hadfield, JA ;
Kendall, A ;
Lawrence, NJ ;
McGown, AT ;
Rennison, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (09) :1051-1056
[7]
DUCKI S, 1997, DEPT CHEM, P237
[8]
GAUKROGER K, 2001, DEPT CHEM, P290
[9]
Rational selection of training and test sets for the development of validated QSAR models [J].
Golbraikh, A ;
Shen, M ;
Xiao, ZY ;
Xiao, YD ;
Lee, KH ;
Tropsha, A .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (02) :241-253
[10]
Hadfield John A, 2003, Prog Cell Cycle Res, V5, P309